U.S. Blood Derivative Diagnostic Agents Companies
Featured companies
Msdx Multiple Sclerosis Diagnostics LLC is a privately held company in Tucson, AZ and is a Single Location business.
Not satisfied? Select a reason•Rate this page•Send feedback
Or try our search form or quick navigation by category and location
Whereorg has 56 results under Blood Derivative Diagnostic Agents Companies in the United States.
Narrow down the browsing criteria below to see more companies.
Other categories
All industries
Chemical Materials In Vitro and In Vivo Diagnostic Substances Blood Derivative Diagnostic Agents
Select a location for category Blood Derivative Diagnostic Agents
Quick navigation
All industries
Chemical Materials
In Vitro and In Vivo Diagnostic Substances
Blood Derivative Diagnostic Agents
Subcategory
- Barium Diagnostic Agents3
- Cytology and Histology Diagnostic Agents15
- Diagnostic Substances592
- Diagnostic Substances, Nec3
- Electrolyte Diagnostic Agents5
- Enzyme and Isoenzyme Diagnostic Agents23
- Hemotology Diagnostic Agents18
- In Vitro Diagnostics447
- In Vivo Diagnostics20
- In-Vitro In-Vivo Diagnostic Substance Manufacturers358
- Microbiology and Virology Diagnostic Products79
- Pregnancy Test Kits102
- Radioactive Diagnostic Substances85
- Veterinary Diagnostic Substances376
All states
Top Stories
UBS flags buyback possibility after Second-quarter earnings beat
UBS , the world's largest wealth manager, on Tuesday signalled the possibility of resuming share buybacks later this year after generating more income than expected in the first six months and as it boosted...
Tue, Jul 21 2020
Greece calls EU recovery fund deal a 'national success'
Prime Minister Kyriakos Mitsotakis called a European Union deal on a post-pandemic recovery fund a "national success" that would allocate Greece around 72 billion euros ($82.38 billion) to help deal with...
Tue, Jul 21 2020
UBS second-quarter net profit dips as Swiss business dampens trading bonanza
UBS , the world's largest wealth manager, saw net profit drop 11% in the second quarter as higher trading activity failed to offset a pandemic-induced slump in retail and corporate banking.
Tue, Jul 21 2020